首页 > 诊治指南 > 2013ACCP肺癌的诊断与治疗指南第3版:肺癌的分子生物学

2013ACCP肺癌的诊断与治疗指南第3版:肺癌的分子生物学

2014-04-15  编辑: faliuxue   来源:CHEST 2013; 143(5)(Suppl):e30S–e39S

  Lung cancer is the leading cause of cancer death in the United States, with 157,000 deaths annually,and in the world, with 1,375,000 deaths annually. The overall 5-year survival for lung cancer remains at 16%, which is signifi cantly lower than the mortality rate for other common cancers, including colon, breast,and prostate cancer. The discrepancy in the mortality rate of lung cancer compared with other cancers has several explanations. First, lung cancers are typically detected at an advanced stage. The anticipated implementation of population-based screening for lung cancer is expected to decrease mortality. Second, compared with the other common cancers that share adenocarcinoma as the histology, lung cancer is heterogenous histologically and biologically.

版权申明:

本网站所有注明“来源:艾兰博曼医学网”的文字、图片和音视频资料,版权均归艾兰博曼医学网所有,欢迎转载,但请务必注明出处“艾兰博曼医学网”,否则将追究法律责任。本网所有注明来源为其他媒体的内容仅出于传递更多信息之目的,版权归原作者所有,不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。

评 论

登 陆后发表评论